Agilent Technologies (NYSE:A – Get Rating) issued an update on its FY22 earnings guidance on Tuesday morning. The company provided EPS guidance of $4.86-4.93 for the period, compared to the consensus EPS estimate of $4.86. The company issued revenue guidance of $6.67-6.73 billion, compared to the consensus revenue estimate of $6.73 billion.Agilent Technologies also updated its FY 2022 guidance to $4.86-$4.93 EPS.
A traded down $1.57 on Tuesday, hitting $124.41. The company had a trading volume of 2,149,569 shares, compared to its average volume of 2,088,196. The company’s fifty day moving average price is $127.21 and its 200 day moving average price is $139.27. Agilent Technologies has a 1-year low of $112.64 and a 1-year high of $179.57. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.19 and a quick ratio of 1.64. The stock has a market cap of $37.37 billion, a price-to-earnings ratio of 31.58, a price-to-earnings-growth ratio of 2.80 and a beta of 1.06.
Agilent Technologies (NYSE:A – Get Rating) last posted its earnings results on Tuesday, May 24th. The medical research company reported $1.13 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.01. Agilent Technologies had a return on equity of 27.04% and a net margin of 18.70%. The firm had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.62 billion. During the same period in the previous year, the company earned $0.97 EPS. The company’s revenue for the quarter was up 5.4% on a year-over-year basis. On average, sell-side analysts forecast that Agilent Technologies will post 4.86 EPS for the current year.
A number of brokerages have recently commented on A. Truist Financial lowered Agilent Technologies from a buy rating to a hold rating in a report on Tuesday, April 19th. Stifel Nicolaus cut their price target on Agilent Technologies from $169.00 to $145.00 and set a hold rating for the company in a report on Wednesday, February 23rd. Robert W. Baird cut their price target on Agilent Technologies from $170.00 to $161.00 in a report on Wednesday, February 23rd. Evercore ISI cut their price target on Agilent Technologies from $170.00 to $155.00 and set an outperform rating for the company in a report on Wednesday, February 23rd. Finally, SVB Leerink lowered their price objective on Agilent Technologies from $175.00 to $145.00 and set an outperform rating on the stock in a research report on Wednesday, February 23rd. Three analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of Buy and an average target price of $163.08.
In other Agilent Technologies news, SVP Michael Tang sold 1,210 shares of the company’s stock in a transaction on Friday, March 18th. The stock was sold at an average price of $136.21, for a total value of $164,814.10. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
A number of institutional investors have recently bought and sold shares of A. Neuberger Berman Group LLC lifted its stake in shares of Agilent Technologies by 8.7% during the first quarter. Neuberger Berman Group LLC now owns 84,268 shares of the medical research company’s stock valued at $11,172,000 after acquiring an additional 6,779 shares during the period. The Manufacturers Life Insurance Company lifted its stake in shares of Agilent Technologies by 22.6% during the first quarter. The Manufacturers Life Insurance Company now owns 324,138 shares of the medical research company’s stock valued at $43,235,000 after acquiring an additional 59,762 shares during the period. Toroso Investments LLC lifted its stake in shares of Agilent Technologies by 13.6% during the first quarter. Toroso Investments LLC now owns 6,182 shares of the medical research company’s stock valued at $818,000 after acquiring an additional 739 shares during the period. Orion Portfolio Solutions LLC lifted its stake in shares of Agilent Technologies by 12.3% during the first quarter. Orion Portfolio Solutions LLC now owns 2,880 shares of the medical research company’s stock valued at $381,000 after acquiring an additional 315 shares during the period. Finally, BNP Paribas Arbitrage SA lifted its stake in shares of Agilent Technologies by 24.7% during the first quarter. BNP Paribas Arbitrage SA now owns 408,780 shares of the medical research company’s stock valued at $54,094,000 after acquiring an additional 80,848 shares during the period.
Agilent Technologies Company Profile (Get Rating)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
- Get a free copy of the StockNews.com research report on Agilent Technologies (A)
- Zoom Video Communications Is Primed To Launch Higher
- Fundamental Strength Makes Williams-Sonoma One for Your Recovery Watchlist
- Institutions Buy The Dip In Petco Health and Wellness Company
- Veeva Systems: Increasing NDR and Other Wins
- Autozone Edges Past Advanced Auto Parts In Q1 2022
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.